BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang A, Li MY, Zhang ZH, Wang JY, Xing Y, Ri M, Jin CH, Xu GH, Piao LX, Jin HL, Zuo HX, Ma J, Jin X. Erianin regulates programmed cell death ligand 1 expression and enhances cytotoxic T lymphocyte activity. J Ethnopharmacol 2021;273:113598. [PMID: 33220359 DOI: 10.1016/j.jep.2020.113598] [Cited by in Crossref: 2] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Yan L, Zhang Z, Liu Y, Ren S, Zhu Z, Wei L, Feng J, Duan T, Sun X, Xie T, Sui X. Anticancer Activity of Erianin: Cancer-Specific Target Prediction Based on Network Pharmacology. Front Mol Biosci 2022;9:862932. [DOI: 10.3389/fmolb.2022.862932] [Reference Citation Analysis]
2 Wang JY, Xing Y, Li MY, Zhang ZH, Jin HL, Ma J, Lee JJ, Zhong Y, Zuo HX, Jin X. Panaxadiol inhibits IL-1β secretion by suppressing zinc finger protein 91-regulated activation of non-canonical caspase-8 inflammasome and MAPKs in macrophages. J Ethnopharmacol 2022;283:114715. [PMID: 34648898 DOI: 10.1016/j.jep.2021.114715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Luo Q, Li X, Gan G, Yang M, Chen X, Chen F. PPT1 Reduction Contributes to Erianin-Induced Growth Inhibition in Oral Squamous Carcinoma Cells. Front Cell Dev Biol 2021;9:764263. [PMID: 35004674 DOI: 10.3389/fcell.2021.764263] [Reference Citation Analysis]
4 Chun KS, Kim DH, Raut PK, Surh YJ. Anticancer natural products targeting immune checkpoint protein network. Semin Cancer Biol 2021:S1044-579X(21)00279-0. [PMID: 34838956 DOI: 10.1016/j.semcancer.2021.11.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Chen J, Huang J, Huang Q, Li J, Chen E, Xu W. RASA4 inhibits the HIFα signaling pathway to suppress proliferation of cervical cancer cells. Bioengineered 2021;12:10723-33. [PMID: 34752201 DOI: 10.1080/21655979.2021.2002499] [Reference Citation Analysis]
6 Trapika IGMGSC, Liu XT, Chung LH, Lai F, Xie C, Zhao Y, Cui S, Chen J, Tran C, Wang Q, Zhang S, Don AS, Li GQ, Hanrahan JR, Qi Y. Ceramide Regulates Anti-Tumor Mechanisms of Erianin in Androgen-Sensitive and Castration-Resistant Prostate Cancers. Front Oncol 2021;11:738078. [PMID: 34604081 DOI: 10.3389/fonc.2021.738078] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tanaka C, Kobori T, Tameishi M, Urashima Y, Ito T, Obata T. Ezrin Modulates the Cell Surface Expression of Programmed Cell Death Ligand-1 in Human Cervical Adenocarcinoma Cells. Molecules 2021;26:5648. [PMID: 34577118 DOI: 10.3390/molecules26185648] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Kobori T, Tanaka C, Tameishi M, Urashima Y, Ito T, Obata T. Role of Ezrin/Radixin/Moesin in the Surface Localization of Programmed Cell Death Ligand-1 in Human Colon Adenocarcinoma LS180 Cells. Pharmaceuticals (Basel) 2021;14:864. [PMID: 34577564 DOI: 10.3390/ph14090864] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Ri MH, Ma J, Jin X. Development of natural products for anti-PD-1/PD-L1 immunotherapy against cancer. J Ethnopharmacol 2021;281:114370. [PMID: 34214644 DOI: 10.1016/j.jep.2021.114370] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
10 Yang L, Wang Z. Natural Products, Alone or in Combination with FDA-Approved Drugs, to Treat COVID-19 and Lung Cancer. Biomedicines 2021;9:689. [PMID: 34207313 DOI: 10.3390/biomedicines9060689] [Cited by in F6Publishing: 14] [Reference Citation Analysis]